Adherence to recommendations for clinical follow-up after benign breast biopsy

M. A. Andrykowski, Janet Carpenter, J. L. Studts, M. J. Cordova, L. L C Cunningham, W. Mager, D. Sloan, D. Kenady, P. McGrath

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Purpose. Women who undergo a benign breast biopsy are at elevated risk for the subsequent development of breast cancer (BC). Therefore, appropriate clinical follow-up of a benign breast biopsy is important. The present study examines the extent and correlates of nonadherence with follow-up recommendations after a benign breast biopsy. Methods. Women (n = 114) who had undergone a benign breast biopsy completed an initial telephone interview within 50 days of their biopsy (mean = 21 days). Additional telephone interviews were completed at 4 and 8 months post-biopsy. Measures of BC risk perception, general and BC-specific distress, BC-related attitudes and beliefs, social support, optimism, and informational coping style were completed. Specific recommendations for clinical follow-up and evidence of actual follow-up were obtained from medical records. Results. Of 103 women given a specific recommendation for clinical follow-up, 34% were classified as nonadherent with follow-up recommendations. Logistic regression analyses indicated that nonadherent women were characterized by younger age, recommendations for follow-up by clinical breast examination alone, greater confidence in their ability to perform breast self-examination properly, higher perceived personal risk for BC, and greater BC-specific distress. Conclusion. Despite the importance of appropriate clinical follow-up of a benign breast biopsy, about one-third of women did not adhere to recommended follow-up. Risk factors for nonadherence suggest potential avenues for interventions to enhance participation in appropriate clinical follow-up.

Original languageEnglish (US)
Pages (from-to)165-178
Number of pages14
JournalBreast Cancer Research and Treatment
Volume69
Issue number2
DOIs
StatePublished - 2001
Externally publishedYes

Fingerprint

Breast
Breast Neoplasms
Biopsy
Interviews
Breast Self-Examination
Aptitude
Social Support
Medical Records
Logistic Models
Regression Analysis

Keywords

  • Adherence
  • Biopsy
  • Breast cancer
  • Clinical follow-up
  • Compliance
  • Psychosocial

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Andrykowski, M. A., Carpenter, J., Studts, J. L., Cordova, M. J., Cunningham, L. L. C., Mager, W., ... McGrath, P. (2001). Adherence to recommendations for clinical follow-up after benign breast biopsy. Breast Cancer Research and Treatment, 69(2), 165-178. https://doi.org/10.1023/A:1012272031953

Adherence to recommendations for clinical follow-up after benign breast biopsy. / Andrykowski, M. A.; Carpenter, Janet; Studts, J. L.; Cordova, M. J.; Cunningham, L. L C; Mager, W.; Sloan, D.; Kenady, D.; McGrath, P.

In: Breast Cancer Research and Treatment, Vol. 69, No. 2, 2001, p. 165-178.

Research output: Contribution to journalArticle

Andrykowski, MA, Carpenter, J, Studts, JL, Cordova, MJ, Cunningham, LLC, Mager, W, Sloan, D, Kenady, D & McGrath, P 2001, 'Adherence to recommendations for clinical follow-up after benign breast biopsy', Breast Cancer Research and Treatment, vol. 69, no. 2, pp. 165-178. https://doi.org/10.1023/A:1012272031953
Andrykowski, M. A. ; Carpenter, Janet ; Studts, J. L. ; Cordova, M. J. ; Cunningham, L. L C ; Mager, W. ; Sloan, D. ; Kenady, D. ; McGrath, P. / Adherence to recommendations for clinical follow-up after benign breast biopsy. In: Breast Cancer Research and Treatment. 2001 ; Vol. 69, No. 2. pp. 165-178.
@article{dd1f7e613f6e4c809f41ac0e19f870f3,
title = "Adherence to recommendations for clinical follow-up after benign breast biopsy",
abstract = "Purpose. Women who undergo a benign breast biopsy are at elevated risk for the subsequent development of breast cancer (BC). Therefore, appropriate clinical follow-up of a benign breast biopsy is important. The present study examines the extent and correlates of nonadherence with follow-up recommendations after a benign breast biopsy. Methods. Women (n = 114) who had undergone a benign breast biopsy completed an initial telephone interview within 50 days of their biopsy (mean = 21 days). Additional telephone interviews were completed at 4 and 8 months post-biopsy. Measures of BC risk perception, general and BC-specific distress, BC-related attitudes and beliefs, social support, optimism, and informational coping style were completed. Specific recommendations for clinical follow-up and evidence of actual follow-up were obtained from medical records. Results. Of 103 women given a specific recommendation for clinical follow-up, 34{\%} were classified as nonadherent with follow-up recommendations. Logistic regression analyses indicated that nonadherent women were characterized by younger age, recommendations for follow-up by clinical breast examination alone, greater confidence in their ability to perform breast self-examination properly, higher perceived personal risk for BC, and greater BC-specific distress. Conclusion. Despite the importance of appropriate clinical follow-up of a benign breast biopsy, about one-third of women did not adhere to recommended follow-up. Risk factors for nonadherence suggest potential avenues for interventions to enhance participation in appropriate clinical follow-up.",
keywords = "Adherence, Biopsy, Breast cancer, Clinical follow-up, Compliance, Psychosocial",
author = "Andrykowski, {M. A.} and Janet Carpenter and Studts, {J. L.} and Cordova, {M. J.} and Cunningham, {L. L C} and W. Mager and D. Sloan and D. Kenady and P. McGrath",
year = "2001",
doi = "10.1023/A:1012272031953",
language = "English (US)",
volume = "69",
pages = "165--178",
journal = "Breast Cancer Research and Treatment",
issn = "0167-6806",
publisher = "Springer New York",
number = "2",

}

TY - JOUR

T1 - Adherence to recommendations for clinical follow-up after benign breast biopsy

AU - Andrykowski, M. A.

AU - Carpenter, Janet

AU - Studts, J. L.

AU - Cordova, M. J.

AU - Cunningham, L. L C

AU - Mager, W.

AU - Sloan, D.

AU - Kenady, D.

AU - McGrath, P.

PY - 2001

Y1 - 2001

N2 - Purpose. Women who undergo a benign breast biopsy are at elevated risk for the subsequent development of breast cancer (BC). Therefore, appropriate clinical follow-up of a benign breast biopsy is important. The present study examines the extent and correlates of nonadherence with follow-up recommendations after a benign breast biopsy. Methods. Women (n = 114) who had undergone a benign breast biopsy completed an initial telephone interview within 50 days of their biopsy (mean = 21 days). Additional telephone interviews were completed at 4 and 8 months post-biopsy. Measures of BC risk perception, general and BC-specific distress, BC-related attitudes and beliefs, social support, optimism, and informational coping style were completed. Specific recommendations for clinical follow-up and evidence of actual follow-up were obtained from medical records. Results. Of 103 women given a specific recommendation for clinical follow-up, 34% were classified as nonadherent with follow-up recommendations. Logistic regression analyses indicated that nonadherent women were characterized by younger age, recommendations for follow-up by clinical breast examination alone, greater confidence in their ability to perform breast self-examination properly, higher perceived personal risk for BC, and greater BC-specific distress. Conclusion. Despite the importance of appropriate clinical follow-up of a benign breast biopsy, about one-third of women did not adhere to recommended follow-up. Risk factors for nonadherence suggest potential avenues for interventions to enhance participation in appropriate clinical follow-up.

AB - Purpose. Women who undergo a benign breast biopsy are at elevated risk for the subsequent development of breast cancer (BC). Therefore, appropriate clinical follow-up of a benign breast biopsy is important. The present study examines the extent and correlates of nonadherence with follow-up recommendations after a benign breast biopsy. Methods. Women (n = 114) who had undergone a benign breast biopsy completed an initial telephone interview within 50 days of their biopsy (mean = 21 days). Additional telephone interviews were completed at 4 and 8 months post-biopsy. Measures of BC risk perception, general and BC-specific distress, BC-related attitudes and beliefs, social support, optimism, and informational coping style were completed. Specific recommendations for clinical follow-up and evidence of actual follow-up were obtained from medical records. Results. Of 103 women given a specific recommendation for clinical follow-up, 34% were classified as nonadherent with follow-up recommendations. Logistic regression analyses indicated that nonadherent women were characterized by younger age, recommendations for follow-up by clinical breast examination alone, greater confidence in their ability to perform breast self-examination properly, higher perceived personal risk for BC, and greater BC-specific distress. Conclusion. Despite the importance of appropriate clinical follow-up of a benign breast biopsy, about one-third of women did not adhere to recommended follow-up. Risk factors for nonadherence suggest potential avenues for interventions to enhance participation in appropriate clinical follow-up.

KW - Adherence

KW - Biopsy

KW - Breast cancer

KW - Clinical follow-up

KW - Compliance

KW - Psychosocial

UR - http://www.scopus.com/inward/record.url?scp=0035174446&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035174446&partnerID=8YFLogxK

U2 - 10.1023/A:1012272031953

DO - 10.1023/A:1012272031953

M3 - Article

VL - 69

SP - 165

EP - 178

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

SN - 0167-6806

IS - 2

ER -